Anti-Human C5 Recombinant Antibody(Eculizumab)

Product Information

Catalog Number	YR1003
Product Name	Anti-Human C5 Recombinant Antibody(Eculizumab)
Molecular Name	Eculizumab
Alias	Anti-C5 Recombinant Antibody, Research Grade Eculizumab
CAS Number	219685-50-4
Molecular Weight	148 kDa
Target	C5[Homo sapiens]
Isotype	IgG2-G4 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, FCM, IP, FuncS, IF, Neut
Buffer	PBS, pH7.5
Background	Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price